Daniel from Improve Press
AI-enabled voice expertise platform Sonde Well being introduced it raised $19.25 million in a Collection B funding spherical led by Companions Funding, bringing its complete elevate to $35.25 million.
KT Company, NEOM Firm and present buyers additionally participated within the spherical, together with cofounder PureTech Well being and M Ventures.
WHAT THEY DO
Sonde Well being makes use of patented voice expertise to detect varied well being situations from biomarkers in an individual’s voice, together with analyzing respiratory health and detecting melancholy and nervousness.
WHAT IT’S FOR
The funding will assist construct out the corporate’s expertise to detect further well being situations, broaden its present respiratory and psychological well being monitoring applied sciences, and drive international industrial development.
“Digital biomarkers have gotten a mainstay in healthcare. At present’s healthcare corporations are realizing how vocal biomarkers can have interaction individuals earlier of their well being. The info and insights present in voice can energy well being monitoring and affected person stratification so points can turn out to be obvious effectively earlier than a pricey medical occasion happens,” David Liu, CEO of Sonde Well being, mentioned in a press release. “With voice and any listening system, accessible and efficient well being monitoring will be made out there to nearly all of the world.”
MARKET SNAPSHOT
Final month, Boston-based Sonde Well being garnered a $2 million strategic funding from South Korean telecommunications big KT Company. KT plans to make use of the tech to improve its AI-powered voice enterprise options and combine Sonde’s expertise into its telemedicine platform in Vietnam.
Sonde Well being licensed its voice expertise from MIT’s Lincoln Laboratory and, in 2018, obtained unique licensing agreements for the patent.
In 2020, the corporate launched its voice API to detect psychological sickness, saying the instrument can detect vocal modifications that would sign one’s psychological state by way of 30-second audio clips and may very well be built-in into third-party apps.
Through the top of the pandemic, it launched a vocal-screening instrument to detect respiratory sickness signs and bought voice-based platform-maker NeuroLex Laboratories.
